It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Originally posted by UnderstandingWisdom
So far this Superbug has been found in U.K, India, Pakistan, Massachusetts, California and Illinois. there has also been at least two cases in Canada
Source:
Medindia.net
Originally posted by kevinunknown
Oh sure people will die of it, but it is by no means a “pandemic”
Originally posted by UnderstandingWisdom
Please read from page 2 to get a better understanding of this soon to be...pandemic (cue scary music).
Originally posted by kevinunknown
By reliable sources I was just pointing out that if I were to write a academic essay about microbiology and Infection control, as I am about to, I would never use any of the sources you have quoted
Originally posted by kevinunknown
I have noticed the only reason you are bothering with this is because you are trying to get you 20 posts
Originally posted by kevinunknown
people will judge you based on the substance of your posts
Originally posted by kevinunknown
Your are telling me how to interpret threads, how to read them and so on I have been about hear longer than you
Originally posted by kevinunknown
The reason I only read the OP during my first post is to avoid being influenced by the other posts I do it with every thread with experience you will learn that can be very useful.
Originally posted by kevinunknown
Welcome to ATS
China's health authorities announced the country's first three cases of NDM-1, a multi-drug resistant super bacteria. Chinese Center for Disease Control and Prevention (China CDC) official Ni Daxin said at a press conference that two cases were detected from samples submitted by the local CDC in the northwestern Ningxia Hui Autonomous Region and one from the southeastern Fujian Province.
The paper looks at the emergence of antimicrobial resistance in the Indian subcontinent, notably the emergence of resistance to one of our major groups of antibiotics, the carbapenems. This emergence of carbapenem resistance in bacteria that are already resistant to many other antibiotics is a major public health concern; carbapenems are often our last effective line of defence against multi-resistant strains of bacteria like Klebsiella pneumoniae and Escherichia coli. If the bacteria become resistant even to carbapenems it makes treatment of these infections much more difficult.
Awareness needs to be raised on an international level, to improve monitoring and surveillance of emerging patterns of resistance, ensure appropriate infection control measures are in place, encourage appropriate regulation of antibiotic use, and help prevent further spread of this resistance.